Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

(BOUVF)

Compare
8.51
0.00
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for BOUVF
  • Previous Close 0.00
  • Open --
  • Bid --
  • Ask --
  • Day's Range --
  • 52 Week Range 8.51 - 8.51
  • Volume --
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BIO-UV Group S.A. designs, manufactures, and markets ultraviolet light water treatment and surface disinfectant devices for individuals and professionals in France, rest of Europe, Asia, the Middle East, the United States, and internationally. It offers O'Clear UV treatment, a disinfection system for water; DELTA-UV, a disinfection system for pools and spas; BIO-UV INOX for a chlorine-free water treatment; BIO-UV COMBIPOOL, an automatic injection and pH regulation for pools; BIO-UV REGUL pH for pools to maintain pH levels; and BIO-UV TEMPO for pools to control the duration of daily remanent injections according to water temperature. The company also provides MP Touch Screen and MPL Super Deluxe for the dechloramination of commercial and semi-commercial pools; DW for the production of drinking water; RW for the tertiary treatment of municipal wastewater disinfection; RW, IAM, and IBP for the treatment of industrial process water; BIO-SEA for the treatment of ballast water on ships; BIO-SUN for water disinfection in remote areas; and BIO-UV Kit UV Home3 3F for domestic water treatment. In addition, it offers HDPE HO/AM for the treatment of aquaculture, fish farming, and leisure ponds water; and UV AND UV HO for the treatment of water in aquariums, zoos, and ocean parks. Further, the company provides BIO-SCAN LIGHT for disinfecting surfaces in communities, medical, commercial and public places, and maritime sector. BIO-UV Group S.A. was founded in 2000 and is headquartered in Lunel, France.

www.bio-uv.com

160

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: BOUVF

View More

Performance Overview: BOUVF

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

BOUVF
0.00%
CAC 40 (^FCHI)
6.15%

1-Year Return

BOUVF
0.00%
CAC 40 (^FCHI)
14.07%

3-Year Return

BOUVF
0.59%
CAC 40 (^FCHI)
7.20%

5-Year Return

BOUVF
0.00%
CAC 40 (^FCHI)
56.08%

Compare To: BOUVF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BOUVF

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    25.91M

  • Enterprise Value

    50.44M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.72%

  • Return on Assets (ttm)

    3.33%

  • Return on Equity (ttm)

    7.67%

  • Revenue (ttm)

    51.29M

  • Net Income Avi to Common (ttm)

    2.42M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.98M

  • Total Debt/Equity (mrq)

    90.11%

  • Levered Free Cash Flow (ttm)

    -8.89M

Research Analysis: BOUVF

View More

Company Insights: BOUVF

Research Reports: BOUVF

View More

People Also Watch